Cisen Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 28.62%

Cisen Pharmaceutical Co Ltd (603367) has an Asset Resilience Ratio of 28.62% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 603367 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥2.24 Billion

≈ $328.13 Million USD Cash + Short-term Investments

Total Assets

CN¥7.83 Billion

≈ $1.15 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Cisen Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Cisen Pharmaceutical Co Ltd.

Liquid Assets Composition Over Time

This chart breaks down Cisen Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Cisen Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.24 Billion	28.62%
Total Liquid Assets	CN¥2.24 Billion	28.62%

Asset Resilience Insights

Very High Liquidity: Cisen Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 28.62% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Cisen Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Cisen Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	Drug Manufacturers - Specialty & Generic	2.79%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Harbin Pharmaceutical Group Co Ltd SHG:600664	Drug Manufacturers - Specialty & Generic	0.97%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Cisen Pharmaceutical Co Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Cisen Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	22.77%	CN¥1.73 Billion ≈ $253.13 Million	CN¥7.60 Billion ≈ $1.11 Billion	+5.89pp
2024-12-31	16.88%	CN¥1.28 Billion ≈ $186.58 Million	CN¥7.55 Billion ≈ $1.11 Billion	-5.44pp
2023-12-31	22.32%	CN¥1.64 Billion ≈ $239.64 Million	CN¥7.34 Billion ≈ $1.07 Billion	-0.42pp
2022-12-31	22.74%	CN¥1.55 Billion ≈ $226.77 Million	CN¥6.82 Billion ≈ $997.26 Million	-0.59pp
2021-12-31	23.33%	CN¥1.48 Billion ≈ $217.25 Million	CN¥6.36 Billion ≈ $931.21 Million	-7.08pp
2020-12-31	30.41%	CN¥1.88 Billion ≈ $274.41 Million	CN¥6.17 Billion ≈ $902.24 Million	-5.30pp
2019-12-31	35.72%	CN¥1.98 Billion ≈ $289.24 Million	CN¥5.53 Billion ≈ $809.76 Million	+35.45pp
2018-12-31	0.27%	CN¥14.33 Million ≈ $2.10 Million	CN¥5.25 Billion ≈ $768.00 Million	-0.15pp
2017-12-31	0.42%	CN¥20.00 Million ≈ $2.93 Million	CN¥4.74 Billion ≈ $693.89 Million	-3.24pp
2016-12-31	3.66%	CN¥120.00 Million ≈ $17.56 Million	CN¥3.28 Billion ≈ $480.08 Million	+1.68pp
2015-12-31	1.98%	CN¥60.00 Million ≈ $8.78 Million	CN¥3.03 Billion ≈ $443.97 Million	--

pp = percentage points

About Cisen Pharmaceutical Co Ltd

SHG:603367 China Drug Manufacturers - Specialty & Generic

Market Cap

$967.28 Million

CN¥6.61 Billion CNY

Market Cap Rank

#9172 Global

#2305 in China

Share Price

CN¥14.60

Change (1 day)

+0.97%

52-Week Range

CN¥12.45 - CN¥24.20

All Time High

CN¥34.05